Blackstone Group »

Apellis Pharmaceuticals shares owned by Blackstone Group

Quarter-by-quarter ownership of Apellis Pharmaceuticals (APLS) shares owned by Blackstone Group from 13F filings

Historical chart of Blackstone Group investment in Apellis Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Apellis Pharmaceuticals held by Blackstone Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apellis Pharmaceuticals by Blackstone Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $511k 13k 40.23

More positions owned by Blackstone Group

Cheniere Energy Partners Com Unit (CQP)
Corebridge Finl (CRBG)
FirstEnergy (FE)
Legence Corp Cl A (LGN)
State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Williams Companies (WMB)
MPLX Com Unit Rep Ltd (MPLX)
Targa Res Corp (TRGP)
Enterprise Products Partners (EPD)
Enbridge (ENB)
Kinder Morgan (KMI)
Energy Transfer Com Ut Ltd Ptn (ET)
Kinetik Holdings Com New Cl A (KNTK)
Cheniere Energy Com New (LNG)
PNM Resources (TXNM)

View all positions for Blackstone Group

Top funds holding Apellis Pharmaceuticals

BlackRock
Wellington Management Company
venBio Select Advisor
Vanguard Group
Morgan Stanley
Rtw Investments
UBS Group
Vanguard Portfolio Management
Pentwater Capital Management
Vanguard Capital Management
State Street Corporation
Deep Track Capital
Point72 Asset Management
Polar Capital Holdings
HBK Investments

View all funds holding Apellis Pharmaceuticals